By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Next generation cephalosporins > Ceftaroline > Ceftaroline Side Effects
Next generation cephalosporins

Ceftaroline Side Effects

Summary

Commonly reported side effects of ceftaroline include: positive direct coombs test. Other side effects include: diarrhea. Continue reading for a comprehensive list of adverse effects.

Applies to ceftaroline: intravenous powder for solution.

Serious side effects of Ceftaroline

Along with its needed effects, ceftaroline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ceftaroline:

More common

  • Back, leg, or stomach pains
  • bleeding gums
  • chills
  • dark urine
  • difficulty with breathing
  • fever
  • general body swelling
  • headache
  • loss of appetite
  • nausea or vomiting
  • nosebleeds
  • pale skin
  • sore throat
  • unusual tiredness or weakness
  • yellowing of the eyes or skin

Less common

  • Black, tarry stools
  • blood in the urine or stools
  • bluish color
  • changes in skin color
  • chest pain, discomfort, or tightness
  • confusion
  • cough
  • decreased frequency or amount of urine
  • diarrhea
  • difficulty with swallowing
  • dizziness
  • dry mouth
  • fast, irregular, pounding, or racing heartbeat or pulse
  • general tiredness and weakness
  • increased blood pressure
  • increased thirst
  • light-colored stools
  • lightheadedness, dizziness, or fainting
  • lower back or side pain
  • mood changes
  • muscle pain or cramps
  • nervousness
  • numbness or tingling in the hands, feet, or lips
  • painful or difficult urination
  • pinpoint red spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • seizures
  • skin itching, rash, redness, or hives
  • slow or irregular heartbeat
  • sores, ulcers, or white spots on the lips or in the mouth
  • stomach cramps, pain, or tenderness
  • swelling of the face, throat, fingers, or lower legs
  • swollen glands
  • trouble breathing
  • unusual bleeding or bruising
  • watery and severe diarrhea, which may also be bloody
  • weakness or heaviness of the legs
  • weight gain

Incidence not known

  • Agitation
  • back pain
  • blurred vision
  • coma
  • hallucinations
  • irritability
  • mood or mental changes
  • shaking or jerking of one area or side of the body
  • stiff neck

Other side effects of Ceftaroline

Some side effects of ceftaroline may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Difficulty having a bowel movement (stool)
  • flushed, dry skin fruit-like breath odor
  • increased hunger
  • increased urination
  • sweating
  • unexplained weight loss
  • welts

For Healthcare Professionals

Applies to ceftaroline: intravenous powder for injection.

General

The most common side effects reported in adults using this drug were diarrhea, headache, nausea, pruritus, and rash.[Ref]

Hematologic

In clinical trials, direct antiglobulin test seroconversion was reported in 10.7% of adult patients using this drug every 12 hours (600 mg infused over 1 hour every 12 hours) and in 32.3% of those using this drug every 8 hours (600 mg infused over 2 hours every 8 hours). Seroconversion from negative to positive direct Coombs test result was reported in 17.9% of children using this drug.

Agranulocytosis, eosinophilia, and leukopenia have also been reported during postmarketing experience.[Ref]

Very common (10% or more): Direct antiglobulin test/Coombs test seroconversion (up to 32.3%), positive direct Coombs test

Uncommon (0.1% to 1%): Anemia, leukopenia, neutropenia, thrombocytopenia, prolonged prothrombin time, prolonged activated partial thromboplastin time, increased INR

Rare (0.01% to 0.1%): Agranulocytosis, eosinophilia[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, nausea, constipation, vomiting, abdominal pain

Uncommon (0.1% to 1%): Clostridioides difficile colitis

Frequency not reported: C difficile-associated diarrhea, dyspepsia[Ref]

Dermatologic

In clinical trials using this drug every 12 hours or every 8 hours, rash was common; however, in a subgroup of Asian patients using this drug every 8 hours, rash was very common (18.5%).[Ref]

Common (1% to 10%): Rash, pruritus, generalized pruritus

Uncommon (0.1% to 1%): Urticaria

Beta-lactam antibiotics (including cephalosporins):

-Postmarketing reports: Severe cutaneous adverse reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms [DRESS], acute generalized exanthematous pustulosis)[Ref]

Nervous system

Risk of encephalopathy was higher in patients with renal dysfunction receiving doses of this drug that were not appropriately reduced.[Ref]

Common (1% to 10%): Headache, dizziness

Frequency not reported: Convulsion

Postmarketing reports: Encephalopathy[Ref]

Metabolic

Common (1% to 10%): Hypokalemia

Frequency not reported: Decreased appetite, hyperglycemia, hyperkalemia[Ref]

Cardiovascular

Common (1% to 10%): Phlebitis, hypertension, increased blood pressure

Frequency not reported: Bradycardia, palpitations[Ref]

Hepatic

Common (1% to 10%): Increased transaminases, increased ALT

Frequency not reported: Abnormal hepatic function, hepatitis, increased AST[Ref]

Other

Common (1% to 10%): Pyrexia

Frequency not reported: Asthenia[Ref]

Psychiatric

Common (1% to 10%): Insomnia[Ref]

Local

Common (1% to 10%): Infusion site reactions (erythema, phlebitis, pain)

Hypersensitivity

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported with beta-lactam antibacterials.[Ref]

Uncommon (0.1% to 1%): Hypersensitivity (e.g., urticaria, lip and face swelling), anaphylaxis[Ref]

Renal

Uncommon (0.1% to 1%): Increased blood creatinine

Frequency not reported: Renal failure[Ref]

Respiratory

Postmarketing reports: Eosinophilic pneumonia

Genitourinary

Frequency not reported: Urinary tract infection[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by